SEMA3A partially reverses VEGF effects through binding to neuropilin-1 B Palodetto, ASS Duarte, MR Lopes, FA Corrocher, FM Roversi, ... Stem cell research 22, 70-78, 2017 | 29 | 2017 |
Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of … FM Roversi, FV Pericole, JA Machado-Neto, ASS Duarte, AL Longhini, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1863 (2), 450-461, 2017 | 29 | 2017 |
Influência dos polimorfismos da glutationa s-transferase na ototoxicidade dos aminoglicosídeos B Palodetto, CRE Grignoli, EL Sartorato, CA Oliveira Brazilian journal of otorhinolaryngology 76, 306-309, 2010 | 16 | 2010 |
C1494T mitochondrial DNA mutation, hearing loss, and aminoglycosides antibiotics B Palodeto, EL Sartorato, CA Oliveira Brazilian Journal of Otorhinolaryngology 75, 884-887, 2009 | 13 | 2009 |
Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell–cell adhesion FM Roversi, MR Lopes, JA Machado-Neto, ALF Longhini, ASS Duarte, ... Stem cells and development 23 (10), 1109-1120, 2014 | 12 | 2014 |
MDR-1 and GST polymorphisms are involved in myelodysplasia progression B Palodetto, P de Melo Campos, BD Benites, MLLF Chauffaille, ... Leukemia Research 37 (8), 970-973, 2013 | 10 | 2013 |
A novel antisense long noncoding RNA modulates NR4A1 protein level in myeloid malignancies FA Corrocher, A Congrains, FS Niemann, B Palodetto, FM Roversi, ... Blood 126 (23), 2442, 2015 | 1 | 2015 |
BRD4 short isoform is a myelodysplasia prognostic marker involved in inappropriate DNA damage response FV Pericole, FM Roversi, ASS Duarte, B Palodetto, FA Corrocher, F Traina, ... Blood 124 (21), 3234, 2014 | 1 | 2014 |
Hematopoietic cell kinase (HCK) is involved in myelodysplastic syndromes and acute leukemia pathophysiology by modulating PI3K pathway and enhancing erythroid differentiation FM Roversi, FV Pericole, JA Machado-Neto, AL Longhini, ASS Duarte, ... Blood 124 (21), 1891, 2014 | 1 | 2014 |
Influência de VEGFA e SEMA3A na patogênese de síndromes mielodisplásicas e leucemias agudas B Palodetto [sn], 2016 | | 2016 |
Knockdown of HCK Reduces Cell Death and Erythroid Differentiation in Human CD34+ Hematopoietic Progenitor Cells FM Roversi, FV Pericole, ASS Duarte, KP Ferro, FA Corrocher, ... Blood 126 (23), 2860, 2015 | | 2015 |
VEGFA is increased in MSC of acute myeloid leukemia bone marrows and may induce proliferation and survival of leukemic cells B Palodetto, M Lopes, F Corrocher, FM Roversi, FS Niemann, AS Duarte, ... MOLECULAR BIOLOGY OF THE CELL 26, 2015 | | 2015 |
The Effects of VEGFA in CD34+ cells. B Palodetto, FA Corrocher, FM Roversi, MO Baratti, P de Melo Campos, ... MOLECULAR BIOLOGY OF THE CELL 25, 2014 | | 2014 |
Investigation of dysregulated pathways involving long non-coding RNA (IncRNA) and gene expression of NR4A1 in myelodysplastic syndromes and acute leukemia. FA Corrocher, B Palodetto, FM Roversi, MO Baratti, P de Melo Campos, ... MOLECULAR BIOLOGY OF THE CELL 25, 2014 | | 2014 |
Downregulation Of SPINT2 Expression In Stromal Cells From Myelodysplastic Syndrome Patients Increases HGF and SDF-1 Secretion and Promotes Cell-Cell Adhesion By Alteration In … FM Roversi, MR Lopes, JA Machado-Neto, AL Longhini, ASS Duarte, ... Blood 122 (21), 2763, 2013 | | 2013 |
Hematopoietic cell kinase (HCK) is highly expressed in myelodysplastic syndrome (MDS) and regulates proliferation, cell cycle progression and hematopoietic differentiation FM Roversi, J Machado-Neto, B Palodetto, FA Corrocher, MO Baratti, ... Blood, The Journal of the American Society of Hematology 120 (21), 3813-3813, 2012 | | 2012 |
Influência dos polimorfismos CYP2B6 G15631T, GSTM1, GSTT1, NQO1 C609T e MDR-1 C3435T na resposta ao tratamento de leucemia aguda e síndrome mielodisplásica B Palodetto Universidade Estadual de Campinas (UNICAMP). Faculdade de Ciências Médicas, 2012 | | 2012 |
MDR-1 and GST Polymorphisms Are Involved in Myelodysplasia Progression B Palodetto, BD Benites, P de Melo Campos, F Traina, STO Saad Blood 118 (21), 3507, 2011 | | 2011 |
Mutação mitocondrial C1494T, deficiência auditiva e uso de antibióticos aminoglicosídeos B Palodeto, EL Sartorato, CA Oliveira Brazilian Journal of Otorhinolaryngology 75, 884-887, 2009 | | 2009 |
C1494t Mitochondrial Dna Mutation, Hearing Loss, And Aminoglycosides Antibiotics [mutação Mitocondrial C1494t, Deficiência Auditiva E Uso De Antibióticos Aminoglicosídeos] M Postal, B Palodeto, EL Sartorato, CA De Oliveira | | |